By Gina Kolata
Federal health officials and Gilead Sciences have settled on priority distribution to Americans — and nonnegotiable pricing.
Published: June 28, 2020 at 08:00PM
from NYT Health https://ift.tt/3dNNVrA
via IFTTT
from WordPress https://ift.tt/2NKuV2w
via IFTTT